Latest Insights - page 34 | BiopharmaTrend

Axiom Bio Launches with $15M to Replace Animal Testing with AI for Drug Toxicity Prediction

San Francisco-based startup founded by Brandon White and Alex Beatson has announced $15 million in seed funding from Amplify Partners, Dimension Capital, and Zetta Ventures, with participation from angels including …

Continue ›››

Raidium Publishes Promptable CT Foundation Model for Tumor Segmentation

Raidium, a Paris-based medical AI company founded in 2022 by radiologist Dr. Paul Hérent and data scientist Pierre Manceron, focuses on developing multimodal foundation models to support radiology and oncology …

Continue ›››

Tempus Introduces Loop, an AI-Driven Platform for Target Discovery and Validation

Tempus AI, Inc. (NASDAQ: TEM) announced the launch of Tempus Loop, a proprietary oncology-focused platform designed to streamline target discovery and validation by integrating real-world patient data (RWD), human-derived biological …

Continue ›››

NHS Wales Pilots Paige AI Tool to Triage Cancer Cases

Paige and NHS Wales have launched a pilot project at Betsi Cadwaladr University Health Board (BCUHB) to evaluate the clinical utility of Paige PanCancer Detect—an AI-powered pathology triage tool trained …

Continue ›››

Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific

Novotech CRO has released a global market analysis focused on the clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF), identifying strategic trends for drug developers targeting this chronic and progressive …

Continue ›››

Immunai and Parker Institute to Build Largest Single-Cell Dataset for Real-World Immunotherapy Research

Immunai and the Parker Institute for Cancer Immunotherapy (PICI) have announced a collaboration to build what they describe as the world’s largest patient-centric single-cell dataset focused on standard-of-care immunotherapy.

Continue ›››

Potato Lands $4.5M to Automate Lab Work with AI and Robots

Seattle-based startup Potato has raised $4.5 million in seed funding to accelerate development of its AI platform for automating scientific research. The company, founded in 2023 by neuroscientist Nick Edwards and …

Continue ›››

Tempus, AstraZeneca, and Pathos Partner to Build Oncology Foundation Model Using Multimodal Data

Tempus has announced new multi-year agreements with AstraZeneca and Pathos AI to co-develop what is described as the largest multimodal foundation model in oncology. The model will be trained on …

Continue ›››

The Rise of AI Agents in Biotech, Where Are We Now?

There's been a growing buzz around “AI agents” across the tech ecosystem, with promises of autonomy, automation, and accelerated discovery. In biotech and drug development, however, their real-world presence is still early-stage. …

Continue ›››

23 New Startups in AI Drug Development Space Launched 2023–2025

A snapshot of emerging startups applying AI across the drug development pipeline—from molecular design to clinical decision support. AI began entering biomedical research in the 1970s through early initiatives like …

Continue ›››

GeneDx to Acquire Fabric Genomics to Enable AI-Powered, Decentralized Genome Interpretation

GeneDx has announced plans to acquire Fabric Genomics, a company specializing in AI-based genomic interpretation, in a move aimed at expanding the reach and flexibility of clinical genomics. The acquisition, …

Continue ›››

Elix and PRISM BioLab Partner to Tackle Hard-to-Drug Protein Targets with AI

Elix and PRISM BioLab have announced a partnership aimed at advancing drug discovery for protein-protein interaction (PPI) targets—an area long considered difficult to address with small molecules. The collaboration brings …

Continue ›››